isoflurane has been researched along with Subarachnoid Hemorrhage in 29 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We recently reported that isoflurane conditioning provided multifaceted protection against subarachnoid hemorrhage (SAH)-induced delayed cerebral ischemia (DCI), and this protection was through the upregulation of endothelial nitric oxide synthase (eNOS)." | 8.02 | Role of SIRT1 in Isoflurane Conditioning-Induced Neurovascular Protection against Delayed Cerebral Ischemia Secondary to Subarachnoid Hemorrhage. ( Athiraman, U; Giri, T; Jayaraman, K; Liu, M; Zipfel, GJ, 2021) |
| "Isoflurane significantly improved neurobehavioral function and brain edema at 24 hrs but not 72 hrs after subarachnoid hemorrhage." | 7.78 | Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice. ( Altay, O; Hasegawa, Y; Khatibi, NH; Sherchan, P; Suzuki, H; Tang, J; Zhang, JH, 2012) |
| "SAH aggravated neurological scores, brain edema, and blood-brain barrier permeability, which were prevented by 2% but not 1% isoflurane posttreatment." | 7.78 | Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. ( Altay, O; Caner, B; Fujii, M; Hasegawa, Y; Krafft, PR; Suzuki, H; Tang, J; Zhang, JH, 2012) |
| "The purpose of this study was to explore whether the changes of plasma concentrations of endothelin (ET) and calcitonin gene-related peptide (CGRP) were possibly involved during desflurane anesthesia in patients undergoing intracranial aneurysm clipping." | 7.72 | Changes of endothelin and calcitonin gene-related peptide during desflurane anesthesia in patients undergoing intracranial aneurysm clipping. ( Luo, F; Shan, R; Wang, T; Zhang, S; Zhao, J; Zhen, Y, 2004) |
| "Volatile sedation after aneurysmal subarachnoid hemorrhage (aSAH) promises several advantages, but there are still concerns regarding intracranial hypertension due to vasodilatory effects." | 5.91 | Volatile Sedation With Isoflurane in Neurocritical Care Patients After Poor-grade Aneurysmal Subarachnoid Hemorrhage. ( Baars, H; Ditz, C; Küchler, J; Leppert, J; Schacht, H; Smith, E; Tronnier, VM, 2023) |
| " Our data show that isoflurane dosing typically used for general anesthesia (1%) or sedation (0." | 5.62 | Anesthetic and subanesthetic doses of isoflurane conditioning provides strong protection against delayed cerebral ischemia in a mouse model of subarachnoid hemorrhage. ( Athiraman, U; Jayaraman, K; Liu, M; Mehla, J; Yuan, J; Zipfel, GJ, 2021) |
| "The first step to treat aneurysmal subarachnoid hemorrhage (SAH) is aneurysmal obliteration under general anesthesia but not treat the SAH itself and the secondary effects." | 5.56 | Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage. ( Altay, BN; Altay, O; Calisir, V; Suzuki, H; Tang, J; Zhang, JH, 2020) |
| "Background Delayed cerebral ischemia remains a common and profound risk factor for poor outcome after subarachnoid hemorrhage (SAH)." | 5.56 | Role of Endothelial Nitric Oxide Synthase in Isoflurane Conditioning-Induced Neurovascular Protection in Subarachnoid Hemorrhage. ( Athiraman, U; Giri, T; Jayaraman, K; Liu, M; Yuan, J; Zipfel, GJ, 2020) |
| "Isoflurane may suppress post-SAH brain inflammation possibly via the sphingosine-related pathway." | 5.40 | Isoflurane on brain inflammation. ( Altay, O; Hasegawa, Y; Ostrowski, RP; Suzuki, H; Tang, J; Zhang, JH, 2014) |
| "Included in the study were 19 consecutive ventilated patients with intracerebral hemorrhage (12), subarachnoid hemorrhage (4), and ischemic stroke (3) who were switched from intravenous propofol or midazolam to inhalative isoflurane sedation for an average of 3." | 5.16 | Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure. ( Bösel, J; Brunn, B; Hacke, W; Nowak, F; Pérez, EB; Poli, S; Purrucker, JC; Renzland, J; Schiller, P; Steiner, T, 2012) |
| "We recently reported that isoflurane conditioning provided multifaceted protection against subarachnoid hemorrhage (SAH)-induced delayed cerebral ischemia (DCI), and this protection was through the upregulation of endothelial nitric oxide synthase (eNOS)." | 4.02 | Role of SIRT1 in Isoflurane Conditioning-Induced Neurovascular Protection against Delayed Cerebral Ischemia Secondary to Subarachnoid Hemorrhage. ( Athiraman, U; Giri, T; Jayaraman, K; Liu, M; Zipfel, GJ, 2021) |
| "Isoflurane significantly improved neurobehavioral function and brain edema at 24 hrs but not 72 hrs after subarachnoid hemorrhage." | 3.78 | Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice. ( Altay, O; Hasegawa, Y; Khatibi, NH; Sherchan, P; Suzuki, H; Tang, J; Zhang, JH, 2012) |
| "SAH aggravated neurological scores, brain edema, and blood-brain barrier permeability, which were prevented by 2% but not 1% isoflurane posttreatment." | 3.78 | Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. ( Altay, O; Caner, B; Fujii, M; Hasegawa, Y; Krafft, PR; Suzuki, H; Tang, J; Zhang, JH, 2012) |
| "The purpose of this study was to explore whether the changes of plasma concentrations of endothelin (ET) and calcitonin gene-related peptide (CGRP) were possibly involved during desflurane anesthesia in patients undergoing intracranial aneurysm clipping." | 3.72 | Changes of endothelin and calcitonin gene-related peptide during desflurane anesthesia in patients undergoing intracranial aneurysm clipping. ( Luo, F; Shan, R; Wang, T; Zhang, S; Zhao, J; Zhen, Y, 2004) |
| "A previous study indicated that diaspirin-crosslinked hemoglobin (DCLHb) decreases cerebral ischemia after subarachnoid hemorrhage." | 3.70 | Subarachnoid molecular hemoglobin after subarachnoid hemorrhage in rats: effect on the area of hypoperfusion. ( Cole, DJ; Cross, LM; Drummond, JC; McKay, LD; Patel, PM, 1998) |
| "Isoflurane is a volatile anesthetic that has a vasodilating effect on cerebral vessels producing a cerebral blood flow increase." | 2.77 | Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow. ( Aletti, G; Citerio, G; Giussani, C; Iacca, C; Molinari, AF; Pesenti, A; Villa, F, 2012) |
| "Patients with subarachnoid hemorrhage were prospectively separated into groups with modest (Fisher grade 1 or 2; n = 8) and severe bleeds (Fisher grade 3; n = 7)." | 2.69 | Hypoxic brain tissue following subarachnoid hemorrhage. ( Ausman, JI; Charbel, FT; Edelman, G; Hoffman, WE; Torres, NJ; Wheeler, P, 2000) |
| "Volatile sedation after aneurysmal subarachnoid hemorrhage (aSAH) promises several advantages, but there are still concerns regarding intracranial hypertension due to vasodilatory effects." | 1.91 | Volatile Sedation With Isoflurane in Neurocritical Care Patients After Poor-grade Aneurysmal Subarachnoid Hemorrhage. ( Baars, H; Ditz, C; Küchler, J; Leppert, J; Schacht, H; Smith, E; Tronnier, VM, 2023) |
| " Our data show that isoflurane dosing typically used for general anesthesia (1%) or sedation (0." | 1.62 | Anesthetic and subanesthetic doses of isoflurane conditioning provides strong protection against delayed cerebral ischemia in a mouse model of subarachnoid hemorrhage. ( Athiraman, U; Jayaraman, K; Liu, M; Mehla, J; Yuan, J; Zipfel, GJ, 2021) |
| "The first step to treat aneurysmal subarachnoid hemorrhage (SAH) is aneurysmal obliteration under general anesthesia but not treat the SAH itself and the secondary effects." | 1.56 | Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage. ( Altay, BN; Altay, O; Calisir, V; Suzuki, H; Tang, J; Zhang, JH, 2020) |
| "Background Delayed cerebral ischemia remains a common and profound risk factor for poor outcome after subarachnoid hemorrhage (SAH)." | 1.56 | Role of Endothelial Nitric Oxide Synthase in Isoflurane Conditioning-Induced Neurovascular Protection in Subarachnoid Hemorrhage. ( Athiraman, U; Giri, T; Jayaraman, K; Liu, M; Yuan, J; Zipfel, GJ, 2020) |
| "Cerebral vasospasm is the most important cause of morbidity after an aneurysm clipping in the early postoperative period." | 1.48 | The effect of anesthetic agents on cerebral vasospasms after subarachnoid hemorrhage: A retrospective study. ( Baik, HJ; Chae, JS; Kim, DY; Lee, JW; Seo, EK; Woo, JH; Yang, NR, 2018) |
| "Isoflurane may suppress post-SAH brain inflammation possibly via the sphingosine-related pathway." | 1.40 | Isoflurane on brain inflammation. ( Altay, O; Hasegawa, Y; Ostrowski, RP; Suzuki, H; Tang, J; Zhang, JH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 8 (27.59) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 3 |
| Yang, X | 3 |
| Cao, Y | 3 |
| Li, X | 3 |
| Xu, R | 3 |
| Yan, J | 3 |
| Guo, Z | 3 |
| Sun, S | 3 |
| Sun, X | 3 |
| Wu, Y | 3 |
| Ditz, C | 1 |
| Baars, H | 1 |
| Schacht, H | 1 |
| Leppert, J | 1 |
| Smith, E | 1 |
| Tronnier, VM | 1 |
| Küchler, J | 1 |
| Liu, M | 4 |
| Jayaraman, K | 4 |
| Norris, AJ | 1 |
| Hussein, A | 1 |
| Nelson, JW | 1 |
| Mehla, J | 2 |
| Diwan, D | 1 |
| Vellimana, A | 1 |
| Abu-Amer, Y | 1 |
| Zipfel, GJ | 4 |
| Athiraman, U | 4 |
| Poon, KS | 1 |
| Pan, YL | 1 |
| Liao, KH | 1 |
| Wang, HL | 1 |
| Chen, KB | 1 |
| Chen, HY | 1 |
| Liu, YC | 1 |
| Lai, TW | 1 |
| Altay, O | 4 |
| Suzuki, H | 4 |
| Altay, BN | 1 |
| Calisir, V | 1 |
| Tang, J | 4 |
| Zhang, JH | 4 |
| Giri, T | 2 |
| Yuan, J | 2 |
| Lee, JW | 1 |
| Woo, JH | 1 |
| Baik, HJ | 1 |
| Kim, DY | 1 |
| Chae, JS | 1 |
| Yang, NR | 1 |
| Seo, EK | 1 |
| Longhi, L | 1 |
| Aresi, S | 1 |
| Villa, F | 2 |
| Citerio, G | 2 |
| Hasegawa, Y | 3 |
| Ostrowski, RP | 1 |
| Mutoh, T | 2 |
| Sasaki, K | 1 |
| Yamamoto, Y | 1 |
| Tsuru, Y | 1 |
| Tsubone, H | 1 |
| Ishikawa, T | 1 |
| Taki, Y | 1 |
| Sherchan, P | 1 |
| Khatibi, NH | 1 |
| Klugmann, M | 1 |
| Caner, B | 1 |
| Krafft, PR | 1 |
| Fujii, M | 1 |
| Iacca, C | 1 |
| Molinari, AF | 1 |
| Giussani, C | 1 |
| Aletti, G | 1 |
| Pesenti, A | 1 |
| Maas, AI | 1 |
| Stocchetti, N | 1 |
| Bösel, J | 1 |
| Purrucker, JC | 1 |
| Nowak, F | 1 |
| Renzland, J | 1 |
| Schiller, P | 1 |
| Pérez, EB | 1 |
| Poli, S | 1 |
| Brunn, B | 1 |
| Hacke, W | 1 |
| Steiner, T | 1 |
| Taplu, A | 1 |
| Gökmen, N | 1 |
| Erbayraktar, S | 1 |
| Sade, B | 1 |
| Erkan, N | 1 |
| Karadibak, K | 1 |
| Arkan, A | 1 |
| Wang, T | 1 |
| Luo, F | 1 |
| Shan, R | 1 |
| Zhen, Y | 1 |
| Zhao, J | 1 |
| Zhang, S | 1 |
| Lavine, SD | 1 |
| Masri, LS | 1 |
| Levy, ML | 1 |
| Giannotta, SL | 1 |
| Cole, DJ | 1 |
| McKay, LD | 1 |
| Drummond, JC | 1 |
| Patel, PM | 1 |
| Cross, LM | 1 |
| Hoffman, WE | 1 |
| Wheeler, P | 1 |
| Edelman, G | 1 |
| Charbel, FT | 1 |
| Torres, NJ | 1 |
| Ausman, JI | 1 |
| Park, KW | 1 |
| Dai, HB | 1 |
| Metais, C | 1 |
| Comunale, ME | 1 |
| Sellke, FW | 1 |
| Abe, K | 1 |
| Iwanaga, H | 1 |
| Yoshiya, I | 1 |
| Graf, BM | 1 |
| Böhrer, H | 1 |
| Gordon, E | 1 |
| Lagerkranser, M | 1 |
| Rudehill, A | 1 |
| von Holst, H | 1 |
| Maissin, F | 1 |
| Mesz, M | 1 |
| Roualdès, G | 1 |
| Bataille, B | 1 |
| Criscuolo, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Inhalatorial Sedation in Patient With SAH Versus Conventional Intravenous Sedation (GAS-SAH)[NCT00830843] | Phase 4 | 13 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for isoflurane and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow.
Topics: Academic Medical Centers; Adult; Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Blood Flow | 2012 |
Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure.
Topics: Aged; Aged, 80 and over; Anesthetics, Inhalation; Cerebral Hemorrhage; Cerebrovascular Circulation; | 2012 |
Hypoxic brain tissue following subarachnoid hemorrhage.
Topics: Adult; Aged; Anesthetics, Inhalation; Body Temperature; Brain Chemistry; Carbon Dioxide; Desflurane; | 2000 |
Carbon dioxide reactivity and local cerebral blood flow during prostaglandin E1- or nitroglycerin-induced hypotension.
Topics: Adult; Aged; Alprostadil; Anesthesia, Inhalation; Blood Pressure; Carbon Dioxide; Cerebrovascular Ci | 1992 |
25 other studies available for isoflurane and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage.
Topics: Animals; Cell Differentiation; Cognition; Electroacupuncture; Isoflurane; Oligodendrocyte Precursor | 2023 |
Volatile Sedation With Isoflurane in Neurocritical Care Patients After Poor-grade Aneurysmal Subarachnoid Hemorrhage.
Topics: Anesthesia; Brain; Cerebrovascular Circulation; Humans; Isoflurane; Retrospective Studies; Subarachn | 2023 |
Isoflurane Conditioning-Induced Delayed Cerebral Ischemia Protection in Subarachnoid Hemorrhage-Role of Inducible Nitric Oxide Synthase.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Isoflurane; Male; Mice; Mice, Inbred C57BL; Mice, Knoc | 2023 |
Isoflurane attenuates carbogen-induced blood-brain barrier disruption independent of body temperature in mice and rats.
Topics: Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Edema; Capillary Permeability; Carbon D | 2020 |
Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage.
Topics: Animals; Apoptosis; Brain Edema; Disease Models, Animal; Isoflurane; Male; Mice; Neuroprotective Age | 2020 |
Role of Endothelial Nitric Oxide Synthase in Isoflurane Conditioning-Induced Neurovascular Protection in Subarachnoid Hemorrhage.
Topics: Anesthetics, Inhalation; Animals; Brain Ischemia; Disease Models, Animal; Endothelium, Vascular; Isc | 2020 |
Anesthetic and subanesthetic doses of isoflurane conditioning provides strong protection against delayed cerebral ischemia in a mouse model of subarachnoid hemorrhage.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Isoflurane; Male; Mice; Mice, | 2021 |
Role of SIRT1 in Isoflurane Conditioning-Induced Neurovascular Protection against Delayed Cerebral Ischemia Secondary to Subarachnoid Hemorrhage.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Fluorescent Antibody Technique; Gene Expression; Is | 2021 |
The effect of anesthetic agents on cerebral vasospasms after subarachnoid hemorrhage: A retrospective study.
Topics: Adult; Anesthetics; Desflurane; Female; Glasgow Coma Scale; Glasgow Outcome Scale; Humans; Intraoper | 2018 |
Volatile anesthetics following subarachnoid hemorrhage.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Cerebrovascular Circulation; Female; Humans; Isof | 2013 |
The authors reply.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Cerebrovascular Circulation; Female; Humans; Isof | 2013 |
Isoflurane on brain inflammation.
Topics: Animals; Brain; Encephalitis; Inflammation Mediators; Isoflurane; Male; Mice; Mice, Inbred Strains; | 2014 |
Isoflurane postconditioning with cardiac support promotes recovery from early brain injury in mice after severe subarachnoid hemorrhage.
Topics: Animals; Brain Injuries; Dobutamine; Heart; Hemodynamics; Isoflurane; Male; Mice; Mice, Inbred C57BL | 2016 |
Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice.
Topics: Animals; Apoptosis; Brain Edema; Brain Injuries; Isoflurane; Lysophospholipids; Male; Mice; Neuropro | 2012 |
Volatile meets versatile: does isoflurane strike a new path to neuroprotection?
Topics: Animals; Apoptosis; Brain Injuries; Isoflurane; Male; Neuroprotective Agents; Subarachnoid Hemorrhag | 2012 |
Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice.
Topics: Anesthetics, Inhalation; Animals; Biomarkers; Blood-Brain Barrier; Blotting, Western; Brain Edema; C | 2012 |
Beware of the Nottingham sheriff when manipulating cerebral blood flow in subarachnoid hemorrhage.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Cerebrovascular Circulation; Female; Humans; Isof | 2012 |
Effects of pressure- and volume-controlled inverse ratio ventilation on haemodynamic variables, intracranial pressure and cerebral perfusion pressure in rabbits: a model of subarachnoid haemorrhage under isoflurane anaesthesia.
Topics: Anesthetics, Inhalation; Animals; Disease Models, Animal; Female; Hemodynamics; Intracranial Pressur | 2003 |
Changes of endothelin and calcitonin gene-related peptide during desflurane anesthesia in patients undergoing intracranial aneurysm clipping.
Topics: Adolescent; Adult; Aged; Anesthesia, Inhalation; Anesthetics, Inhalation; Blood Pressure; Calcitonin | 2004 |
Temporary occlusion of the middle cerebral artery in intracranial aneurysm surgery: time limitation and advantage of brain protection.
Topics: Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenous; Aneurysm, Ruptured; Brai | 1997 |
Subarachnoid molecular hemoglobin after subarachnoid hemorrhage in rats: effect on the area of hypoperfusion.
Topics: Analysis of Variance; Anesthetics, Inhalation; Animals; Antipyrine; Aspirin; Blood; Blood Substitute | 1998 |
Isoflurane does not further impair microvascular vasomotion in a rat model of subarachnoid hemorrhage.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Anestheti | 2002 |
[A fatal hypertensive reaction during anesthesia in a patient with acute subarachnoid hemorrhage].
Topics: Anesthesia, Inhalation; Female; Humans; Hypertension; Intracranial Aneurysm; Isoflurane; Middle Aged | 1990 |
The effect of isoflurane on cerebrospinal fluid pressure in patients undergoing neurosurgery.
Topics: Adult; Aged; Anesthesia, General; Brain Neoplasms; Cerebrovascular Circulation; Female; Humans; Intr | 1988 |
[Hypotension induced by isoflurane for the treatment of intracranial aneurysm in late pregnancy].
Topics: Adult; Cesarean Section; Female; Fetal Monitoring; Humans; Hypotension, Controlled; Intracranial Ane | 1987 |